Identification of Candida dubliniensis in a HIV-positive South African population

South African Medical Journal

Volumn 91, Issue 12, 2001, Pages 599-601

  Fisher, J M ^a   Basson, N J ^a   van Zyl, A ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Candida dubliniensis; HIV; South Africa

Indexed keywords

FLUCONAZOLE; BETA GLUCOSIDASE; CHROMOGENIC SUBSTRATE; DIAGNOSTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CANDIDA DUBLINIENSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESISTANCE; EUROPE; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NORTH AMERICA; PATHOGENESIS; POPULATION; PREVALENCE; SEROCONVERSION; SOUTH AFRICA; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS; YEAST; AIDS RELATED COMPLEX; BACTERIAL COUNT; CANDIDA; CANDIDA ALBICANS; CHILD; CLASSIFICATION; GROWTH, DEVELOPMENT AND AGING; LUNG TUBERCULOSIS; MICROBIOLOGY; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BETA-GLUCOSIDASE; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CHILD; CHROMOGENIC COMPOUNDS; COHORT STUDIES; COLONY COUNT, MICROBIAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 0035708530     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Oral manifestations of HIV infection in 600 South African patients
2. New and emerging pathogens
3. Candida glabrata: Review of epidemiology, pathogenesis and clinical disease with comparison to C. albicans
4. Candida dubliniensis sp. nov: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
5. Candida dubliniensis: Characteristics and identification
6. Evaluation of phenotypical markers for selection and identification of Candida dubliniensis
7. Identification of Candida dubliniensis in a prospective study of patients in the United States
8. Retrospective identification and characterisation of Candida dubliniensis isolates among Candida albicans laboratory isolates from human immunodeficiency virus (HIV)-infected and non HIV-infected individuals
9. The role of Candida dubliniensis in oral candidosis in human immunodeficiency virus infected individuals
10. Candida dubliniensis: Philogeny and putative virulence factors
11. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients
12. Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States
13. Paediatric AIDS-related linear gingival erythema: A form of erythematous candidiasis
14. Coagulation of Candida dubliniensis with Fusobacterium nucleatum
15. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions
16. In vitro susceptibility of Candida dubliniensis to current and new anti fungal agents
17. Isolation of Candida dubliniensis from the oral cavity of an HIV positive child in Brazil
18. Recovery of Candida dubliniensis from human immunodeficiency virus-infected patients in Israel
19. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals
20. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates
21. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity
22. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis
23. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans
24. Cluster of atypical Candida isolates in a group of human immunodeficiency virus-positive drug users
25. CHROMagar candida, a new differential isolation medium for presumptive identification of clinically important Candida species
26. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients
27. Rapid identification of Candida dubliniensis with commercial yeast identification systems
28. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucosidase as determined with the API 20C AUX and vitek YBC systems
29. Candidiasis: The emergence of a novel species, Candida dubliniensis